Neurosciences
ROCHESTER, Minn. — An international study led by Mayo Clinic researchers has identified interleukin-6 (IL-6) receptor blockers as a promising option for preventing relapses in[...]
Latest stories
Research
September 3, 2024
Cardiovascular
September 3, 2024
Individualized Medicine
August 29, 2024
Sign up to receive email notifications
Explore more topics
Sign up
Mayo Clinic Connect
An online patient support community